help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burger, H. G.
Right arrow Articles by Robertson, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burger, H. G.
Right arrow Articles by Robertson, D. M.
Endocrinology Vol. 138, No. 4 1361-1362
Copyright © 1997 by The Endocrine Society


ARTICLES

Editorial: Inhibin in the Male—Progress at Last1

Henry G. Burger and David M. Robertson

Prince Henry’s Institute of Medical Research, Monash Medical Centre, Clayton, Victoria, 3168, Australia

Address all correspondence and requests for reprints to: Professor Henry G. Burger, Prince Henry’s Institute of Medical Research, Monash Medical Centre, Clayton, Victoria, 3168, Australia.


    Introduction
 Top
 Introduction
 References
 
Inhibin is a glycoprotein hormone, which inhibits the production and/or secretion of the pituitary gonadotropins, preferentially FSH. (1). The ability of aqueous rodent testicular extracts to inhibit the formation of castration cells in the anterior pituitary, whereas organic solvent extracts failed to do so, provided the basis of the "inhibin hypothesis" more than 60 years ago (2). Subsequently, both human seminal plasma (3) and bovine testicular extracts (4) were shown to suppress specifically FSH levels in castrate rats and sheep, respectively, consistent with the possibility that the testis was capable of inhibin production and confirmed by the selective FSH suppression induced by the infusion of recombinant human inhibin into several species (5, 6). Cultured rat Sertoli cells were shown to be capable of secreting bioassayable inhibin, and it was thus postulated that the testicular source was the Sertoli cell (7). Inhibin was first purified from ovarian sources (for review, see Ref.8), and bovine ovarian inhibin was used as the antigen in one of the first inhibin RIAs to be fully characterized and applied to the study of inhibin physiology (9), an RIA known widely as the Monash assay.

The cloning of human inhibin showed that there were two major species, inhibins A and B, dimers which shared a common {alpha}-subunit, disulphide-linked to one of two different ß subunits, ßA or ßB. Both of these inhibins were shown to be detectable by the RIA, as were peptides related to the inhibin {alpha}-subunit.

While the application of the RIA to studies of inhibin physiology in the female has generated data consistent with a physiological role for inhibin in women (10), problems arose with data generated in men. Initial studies as reviewed (11) were promising. Immunoreactive inhibin levels were elevated at the time of hypothalamo-pituitary-testicular axis activation in young boys and rose during normal human puberty, being correlated with rising levels of the gonadotropins and testosterone. Levels fell with increasing age in men, were suppressed by exogenous testosterone administration, and responded to the administration of both FSH and human CG, suggesting the possibility of dual gonadotropic control, a somewhat unexpected finding.

In contrast, in states of disordered spermatogenesis, leading to human male infertility, no correlation could be found between FSH and immunoreactive inhibin, with levels in severe spermatogenic failure, e.g. Klinefelter’s syndrome, often being normal or even raised (12).

Elaboration of the inhibin hypotheses had postulated that it was a factor produced by the seminiferous epithelium (specifically the Sertoli cell), involved in the regulation of FSH, whereas Leydig cell testosterone was the primary feedback factor for LH. Testosterone was known to be capable of FSH suppression. The failure to find a correlation between FSH and inhibin in disorders of the seminiferous epithelium was puzzling. When it became clear that inhibin {alpha}-subunit related peptides were present in the circulation (13) and that cultured rat testicular Leydig cells could secrete immunoreactive inhibin and could be stimulated by LH (14), an explanation for the paradoxical findings in Klinefelter’s syndrome and other forms of male infertility could be postulated. It was possible that bioactive inhibin normally secreted by the Sertoli cell was absent but that the Leydig cells, and where evident, Sertoli cells remaining in the testis of severely infertile men, were capable of producing immunoreactive inhibin species without biological activity, hence leading to elevated FSH levels.

The recent and clearly very important development of assays specific for the dimeric inhibins, A (15) and B (16), has shed some light on the situation, particularly the recent demonstration that inhibin B, which is inducible by exogenous FSH (17), is the only inhibin detectable in adult men and that its levels are very low in men with Klinefelter’s syndrome and other forms of severe male infertility. A recent and rapidly growing body of evidence is consistent with inhibin B being the relevant physiological inhibin involved in FSH negative feedback in the male. In this issue (18), evidence is reported that inhibin B is present in the circulation of the juvenile Rhesus monkey whose pituitary-testicular axis has been driven by intermittent iv GnRH infusion, though it is not clear from the data presented that FSH specifically stimulated levels of inhibin B in this situation. While persuasive evidence is accumulating that inhibin B may represent a physiologically relevant species, no clear cut explanation has been found for the quantitatively much larger amounts of {alpha}-subunit related immunoreactivity present in male serum and apparently responsive to FSH stimulation as shown both in the human male and in the present report in juvenile Rhesus monkeys. What is the function of {alpha} subunit-related peptides? Do they necessarily arise from the testis? Some evidence suggests that they may not (19).

Further complexities have been identified by the recognition that inhibin in serum is present in a variety of molecular weight forms due, in the main, to cleavage at specific sites on both subunits. Thus, inhibin is found in human serum as the mature 30K ({alpha}ß) dimer with extensions of either or both subunits resulting in additional mol wt species of 50–70K and 90–110K (20). It would also appear that inhibin A and B are processed differentially in serum, with the {alpha}-subunit precursor of inhibin B more readily cleaved than that of inhibin A (21). Recent studies by Mason (22) have showed that the in vitro biological activity of noncleavable high molecular weight forms of inhibin produced by recombinant expression was markedly reduced, suggesting that processing of inhibins may be critical for biological activity. It would thus appear that inhibin biological activity is dependent on the degree of subunit processing either in the circulation or at the pituitary.

While results from the present paper highlight some of these structural complexities, it does appear that there are differences between the human and monkey. In the human, {alpha}-subunit immunoassays including the Monash RIA are able to readily detect high molecular weight forms of inhibin (20, 21), whereas in the monkey, even though high molecular weight forms are measurable as seen in Figs. 1 and 2 of Majumdar et al. (18), they are seemingly poorly detected, at least in stored serum (Fig. 4). It will clearly be important to resolve the basis for these apparent differences particularly if there are questions of assay specificity.

Over a number of years, Plant and colleagues have undertaken a series of studies using elegant physiological models to explore the regulation by testicular factors of FSH secretion in monkeys. Earlier studies examined the effects of inhibin immunoneutralization (23) and recombinant inhibin administration on FSH secretion (6), as well as the contribution of testosterone to suppressing FSH. In this issue (18), these authors have continued these studies by exploring the stimulatory effects of of FSH and LH (human CG) on inhibin production. FSH showing a clear stimulatory effect on inhibin levels in contrast to the absence of effects of CG despite supraphysiological circulating testosterone levels. These studies have established the overall importance of inhibin, and the limited importance of testosterone in regulating FSH in the monkey and extend studies undertaken in other species.

The present discussion has focused only on the characteristics of the long loop feedback system between the pituitary and the testis. The local intrapituitary production of the inhibin-related peptides (11) no doubt complicates any of the interpretations proposed. It is also interesting to comment on the complexity of the pituitary-testicular feedback system. Not only is it clear that a variety of inhibin species is present in the circulation, at least some of which appear very likely to be of testicular origin, it is also clear that both FSH and LH exist in multiple isoforms of various biological and immunological activity. It is difficult to postulate reasons for the apparent complexity of the reproductive axis control system, in contrast with what appear to be relatively much simpler systems in the control of thyroid and adrenocortical function.


    Footnotes
 
1 This work was supported by Program Grant 943208 of the National Health and Medical Research Council of Australia. Back

Received February 3, 1997.


    References
 Top
 Introduction
 References
 

  1. Burger HG, Igarashi M 1988 Inhibin:definition and nomenclature, including related substances. J Clin Endocrinol Metab 66:885–886[Medline]
  2. McCullagh DR 1932 Dual endocrine activity of the testis. Science 79:19–20
  3. Franchimont P 1972 Human gonadotrophin secretion. J R Coll Physicians Lond 6:283–297[Medline]
  4. Keogh EJ, Lee VWK, Rennie GC, Burger HG, Hudson B, de Kretser DM 1976 Selective suppression of FSH by testicular extracts. Endocrinology 98:997–1002[Abstract]
  5. Tilbrook AJ, de Kretser DM, Clarke IJ 1992 A role for inhibin in the regulation of the secretion of follicle stimulating hormone in male domestic species. Domest Anim Endocrinol 9:243–260[CrossRef][Medline]
  6. Majumdar SS, Mikuma N, Ishwad PC, Winters SJ, Attardi BJ, Perera AD, Plant TM 1995 Replacement with recombinant human inhibin immediately following orchidectomy in the hypophysiotropically clamped male rhesus monkey (Macaca mulatta) maintains follicle stimulating hormone (FSH) secretion and FSHß messenger RNA levels at precastration values. Endocrinology 136:1969–1977[Abstract]
  7. Steinberger A, Steinberger E 1976 Secretion of an FSH-inhibiting factor by cultured Sertoli cells. Endocrinology 99:918–921[Abstract]
  8. de Kretser DM, Robertson DM 1989 The isolation and physiology of inhibin and related proteins. Biol Reprod 40:33–47[Abstract]
  9. McLachlan RI, Robertson DM, Burger HG, de Kretser DM 1986 The radioimmunoassay of bovine and human follicular fluid and serum inhibin. Mol Cell Endocrinol 46:175–185[CrossRef][Medline]
  10. Baird DT, Smith KB 1993 Inhibin and related peptides in the regulation of reproduction. Oxf Rev Reprod Biol 15:191–232[Medline]
  11. Burger HG 1992 Inhibin. Reprod Med Rev 1:1–20
  12. de Kretser DM, McLachlan RI, Robertson DM, Burger HG 1989 Serum inhibin levels in normal men and men with testicular disorders. J Endocrinol 120:517–523[Abstract/Free Full Text]
  13. Schneyer AL, Mason AJ, Burton LE, Ziegner JR, Crowley Jr WF 1990 Immunoreactive inhibin {alpha} subunit in human serum: implications for radioimmunoassay. J Clin Endocrinol Metab 70:1208–1212[Abstract]
  14. Risbridger GP, Clements J, Robertson DM, Drummond AE, Muir J, Burger HG, de Kretser DM 1989 Immuno- and bioactive inhibin and {alpha}-subunit expression in rat Leydig cell cultures. Mol Cell Endocrinol 66:119–122
  15. Groome NP, O’Brien M Pal R, Rodger FE, Mather JP, McNeilly AS 1993 Two site immunoassays for inhibin and its subunits. Further applications of the synthetic peptide approach. J Immunol Methods 165:167–176
  16. Groome NP, Illingworth PJ, O’Brien M, Pal R, Rodger FE, Mather JP, McNeilly AS 1996 Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 81:1401–1405[Abstract]
  17. Anawalt BD, Bebb RA, Matsumato AM, Groome NP, Illingworth PJ, McNeilly AS, Bremner WJ 1996 Serum inhibin B levels reflect Sertoli cell function in normal men and in men with testicular dysfunction. J Clin Endocrinol Metab 81:3341–3345[Abstract]
  18. Majumdar SS, Winters SJ, Plant TM 1997 A study of the relative roles of follicle-stimulating hormone and luteinizing hormone in the regulation of testicular inhibin secretion in the Rhesus monkey (Macaca mulatta). Endocrinology 138:1363–1373[Abstract/Free Full Text]
  19. Lambert-Messerlian GM, Crowley Jr WF, Schneyer AL 1995 Extragonadal {alpha}-inhibin precursor proteins circulate in human male serum. J Clin Endocrinol Metab 80:3043–3049[Abstract/Free Full Text]
  20. Robertson DM, Burger HG, Sullivan J, Cahir N, Groome N, Poncelet E, Franchimont P, Woodruff T, Mather JP 1996 Biological and immunological characterization of inhibin forms in human plasma. J Clin Endocrinol Metab 81:669–676[Abstract]
  21. Robertson DM, Cahir N, Findlay JK, Burger HG, Groome N 1997 The biological and immunological characterization of inhibin A and B forms in human follicular fluid and plasma. J Clin Endocrinol Metab 82:889–896[Abstract/Free Full Text]
  22. Mason AJ, Farnworth PG, Sullivan J 1996 Characterization and determination of the biological activities of noncleavable high molecular weight forms of inhibin A and activin A. Mol Endocrinol 10:1055–1065[Abstract]
  23. Medhamurthy R, Abeyawardene SA, Culler MD, Negro-Vilar A, Plant TM 1990 Immunoneutralization of circulating inhibin in the hypophysiotropically clamped male rhesus monkey (Macaca mulatta) results in a selective hypersecretion of follicle stimulating hormone. Endocrinology 126:2116–2124[Abstract]



This article has been cited by other articles:


Home page
Hum ReprodHome page
V. Sundblad, V. A. Chiauzzi, L. Andreone, S. Campo, E. H. Charreau, and L. Dain
Controversial role of inhibin {alpha}-subunit gene in the aetiology of premature ovarian failure
Hum. Reprod., May 1, 2006; 21(5): 1154 - 1160.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E.V. Velasquez, R.V. Trigo, S. Creus, S. Campo, and H.B. Croxatto
Pituitary-ovarian axis during lactational amenorrhoea. I. Longitudinal assessment of follicular growth, gonadotrophins, sex steroids and inhibin levels before and after recovery of menstrual cyclicity
Hum. Reprod., April 1, 2006; 21(4): 909 - 915.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
L L Burger, D J Haisenleder, A C Dalkin, and J C Marshall
Regulation of gonadotropin subunit gene transcription
J. Mol. Endocrinol., December 1, 2004; 33(3): 559 - 584.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. O'Donnell, K. M. Robertson, M. E. Jones, and E. R. Simpson
Estrogen and Spermatogenesis
Endocr. Rev., June 1, 2001; 22(3): 289 - 318.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. J. Winters and T. M. Plant
Partial Characterization of Circulating Inhibin-B and Pro-{alpha}C During Development in the Male Rhesus Monkey
Endocrinology, December 1, 1999; 140(12): 5497 - 5504.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
J. M. Martin-Villa, J. Longás, and A. Arnáiz-Villena
Cyclic Expression of HLA Class I and II Molecules on the Surface of Purified Human Spermatozoa and Their Control by Serum Inhibin B Levels
Biol Reprod, December 1, 1999; 61(6): 1381 - 1386.
[Abstract] [Full Text]


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burger, H. G.
Right arrow Articles by Robertson, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burger, H. G.
Right arrow Articles by Robertson, D. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals